Salivary biomarkers in oral squamous cell carcinoma
10.5125/jkaoms.2020.46.5.301
- Author:
Truc Thi Hoang NGUYEN
1
;
Buyanbileg SODNOM-ISH
;
Sung Weon CHOI
;
Hyo-Il JUNG
;
Jaewook CHO
;
Inseong HWANG
;
Soung Min KIM
Author Information
1. Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea
- Publication Type:REVIEW ARTICLE
- From:Journal of the Korean Association of Oral and Maxillofacial Surgeons
2020;46(5):301-312
- CountryRepublic of Korea
-
Abstract:
In disease diagnostics and health surveillance, the use of saliva has potential because its collection is convenient and noninvasive. Over the past two decades, the development of salivary utilization for the early detection of cancer, especially oral cavity and oropharynx cancer has gained the interest of the researcher and clinician. Until recently, the oral cavity and oropharynx cancers are still having a five-year survival rate of 62%, one of the lowest in all major human cancers. More than 90% of oral cancers are oral squamous cell carcinoma (OSCC). Despite the ease of accessing the oral cavity in clinical examination, most OSCC lesions are not diagnosed in the early stage, which is suggested to be the main cause of the low survival rate. Many studies have been performed and reported more than 100 potential saliva biomarkers for OSCC. However, there are still obstacles in figuring out the reliable OSCC salivary biomarkers and the clinical application of the early diagnosis protocol. The current review article discusses the emerging issues and is hoped to raise awareness of this topic in both researchers and clinicians. We also suggested the potential salivary biomarkers that are reliable, specific, and sensitive for the early detection of OSCC.
